VS

Vivek Singh Kushwah

Active Director Director DIN 10076836
DIN 10076836 First appointment Mar 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Vivek Singh Kushwah

Data last updated:

Vivek Singh Kushwah is a Director at Puerile Dermaceuticals Private Limited (since 2023). Puerile Dermaceuticals Private Limited reported revenue of ₹46.4 Lakh (FY 2025).

DIN 10076836
Primary Designation Director
First Appointment 17 Mar 2023
Oldest Company Age 3 yrs
Largest company Puerile Dermaceuticals Private Limited · ₹46.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Mar 20232023₹46.4 Lakh (FY 2025)Active

Board colleagues of Vivek Singh Kushwah

NameDINCompanyDesignation
Mithlesh Kumari10076835Puerile Dermaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Puerile Dermaceuticals Private Limited
Premium access

Shareholding and investment profile for Vivek Singh Kushwah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivek Singh Kushwah

Vivek Singh Kushwah currently holds 1 directorship: Puerile Dermaceuticals Private Limited (Director, since 17 Mar 2023, revenue ₹46.4 Lakh (FY 2025)).

Vivek Singh Kushwah was first appointed on 17 Mar 2023 as Director at Puerile Dermaceuticals Private Limited.

The current boards of Vivek Singh Kushwah's companies include Mithlesh Kumari (Puerile Dermaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available